Recalls / Active ingredient / Paroxetine Hydrochloride Anhydrous

Paroxetine Hydrochloride Anhydrous

7 FDA drug recalls involving the active ingredient “Paroxetine Hydrochloride Anhydrous”.

Date	Class	Product	Firm
2023-11-10	Class II	PAROXETINE tablets, USP, 20 mg, Packaged as a) 90-count bottle NDC 60429-735-90; b)1000-count bottle, NDC 6042	Golden State Medical Supply Inc.
2023-11-10	Class II	PAROXETINE tablets, USP, 40 mg, Packaged as a) 30-count bottle, NDC 60429-737-30; b) 90-count bottle NDC 6042	Golden State Medical Supply Inc.
2023-11-10	Class II	PAROXETINE tablets, USP, 10 mg, Packaged as a) 30-count bottle, NDC 60429-734-30; b) 90-count bottle NDC 6042	Golden State Medical Supply Inc.
2023-11-01	Class II	Paroxetine Hydrochloride Tablets USP, RX only, 20 mg, a) 100-count bottle, NDC#:60505-0083-2; b) 1000-count b	Apotex Corp.
2023-11-01	Class II	Paroxetine Hydrochloride Tablets USP, RX only, 30 mg, a)30-count bottle, NDC#: 60505-0084-1, b)100-count bottl	Apotex Corp.
2023-11-01	Class II	Paroxetine Hydrochloride Tablets USP, RX only, 40 mg, 1000-count bottle, NDC#:60505-0101-4 Manufactured by: Ap	Apotex Corp.
2023-11-01	Class II	Paroxetine Hydrochloride Tablets USP, RX only, 10 mg a) 30-count bottle, NDC#: 60505-0097-1; b) 100-count bo	Apotex Corp.